Vascular Grafts Market Size to Cross USD 3.7 Bn by 2031 | Transparency Market Research

In 2021, the global 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐆𝐫𝐚𝐟𝐭𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 size reached US$ 2.0 billion. Projections indicate a steady growth trajectory, with an expected Compound Annual Growth Rate (CAGR) of 5.6% from 2022 to 2031. By the close of 2031, it is anticipated to exceed US$ 3.7 billion.

The utilization of vascular grafts is experiencing a notable uptick, attributed to the escalating prevalence of health conditions like chronic kidney and cardiovascular diseases.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=11096&utm_source=OpenPR&utm_campaign=MansiR

Several factors contribute to the increasing demand for vascular graft surgeries or procedures, including the rise in lifestyle-related disorders, expansion of the geriatric population, augmented healthcare expenditure, and enhancements in healthcare infrastructure.

Vascular surgery entails redirecting obstructed or constricted arteries to restore blood flow to a particular organ, such as the heart, brain, or legs. Surgeons employ either synthetic or natural grafts to establish a connection between a healthy artery and the narrowed artery beyond the blockage, creating an alternative path for blood circulation. Various forms of vascular bypass graft surgeries are available, depending on the location of the blockage.

Vascular bypass graft surgery is an inpatient procedure conducted by a cardiothoracic surgeon, neurosurgeon, or vascular surgeon within a hospital setting. Bypass surgeries are typically scheduled in advance. Each bypass surgery necessitates the selection of a suitable graft to facilitate the creation of a new pathway around the blocked segment of the artery.

𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

B. Braun SE, Becton, Dickinson and Company, Cook Medical, Inc., CryoLife, Inc., Getinge AB, Heart Medical, Junken Medical Co., Ltd., LeMaitre Vascular, Inc., Medtronic, Vascular Graft Solutions, and W. L. Gore & Associates, Inc.

𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧:

𝐏𝐫𝐨𝐝𝐮𝐜𝐭

Endovascular Stent Graft
Peripheral Vascular Graft
Hemodialysis Access Graft
Bypass Graft
Others

𝐒𝐨𝐮𝐫𝐜𝐞

Synthetic

Polytetrafluethylene (PTFE)
Polyurethane (PU)
Dacron
Others

Biological

Bovine Vein
Saphenous Vein
Others

Biosynthetic

Ovine Collagen with Polyester
Others

𝐒𝐢𝐳𝐞 𝐨𝐟 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐆𝐫𝐚𝐟𝐭

Large Size Vascular Graft
Small Size Vascular Graft

𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Coronary Artery Bypass
Aneurysm
Vascular Occlusion
Critical Limb Ischemia
Renal Failure
Others

𝐄𝐧𝐝-𝐮𝐬𝐞𝐫

Hospitals
Ambulatory Surgery Centers
Cardiac Catheterization Laboratories
Specialty Clinics
Others

𝐑𝐞𝐠𝐢𝐨𝐧𝐬 𝐂𝐨𝐯𝐞𝐫𝐞𝐝:

North America(USA, Canada and Mexico)
Europe(UK, Germany, France and the Rest of Europe)
Asia Pacific(China, Japan, India, and the Rest of the Asia Pacific region)
South America(Brazil, Argentina and the Rest of South America)
Middle East and Africa(GCC and Rest of the Middle East and Africa)

𝐏𝐥𝐚𝐜𝐞 𝐚𝐧 𝐎𝐫𝐝𝐞𝐫 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.transparencymarketresearch.com/checkout.php?rep_id=11096<ype=S&utm_source=OpenPR&utm_campaign=MansiR

𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐫𝐢𝐯𝐞𝐫𝐬 𝐚𝐧𝐝 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

𝐃𝐫𝐢𝐯𝐞𝐫𝐬:

Increasing prevalence of vascular diseases
Technological advancements in graft materials and manufacturing processes
Growing geriatric population
Rising healthcare expenditure

𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬:

High cost associated with vascular graft procedures
Limited reimbursement policies
Stringent regulatory requirements

𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬:

Shift towards minimally invasive vascular procedures
Growing adoption of tissue-engineered vascular grafts
Increasing focus on research and development of advanced graft materials
Rising demand for biodegradable vascular grafts

𝐊𝐞𝐲 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬:

In September 2021, Terumo Aortic announced the launch of its global surgical graft study, known as 'PANTHER'

In March 2021, Vascular Graft Solutions, one of the leading manufacturers of medical devices, announced receipt of marketing clearance from the Food and Drug Administration (FDA) for 'VIOLA', a new device for clampless proximal anastomosis in coronary artery bypass grafting (CABG)

In November 2019, Terumo Corporation acquired Aortica Corporation to expand its product line

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐮𝐝𝐲 𝐏𝐨𝐢𝐧𝐭𝐬:

Market size and growth projections
Key market segments and their growth prospects
Regional analysis and market dynamics
Market drivers and challenges
Competitive landscape and recent developments
Future outlook and growth opportunities

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 𝐛𝐲 𝐓𝐌𝐑:

𝐑𝐚𝐝𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐓𝐡𝐞𝐫𝐚𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/04/03/2640209/0/en/Radiopharmaceutical-Theranostics-Market-Size-to-Cross-USD-12-4-Bn-by-2031-Transparency-Market-Research.html

𝐇𝐞𝐦𝐨𝐬𝐭𝐚𝐬𝐢𝐬 𝐕𝐚𝐥𝐯𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭- https://www.globenewswire.com/news-release/2023/04/03/2640107/0/en/Hemostasis-Valves-Market-Revenue-to-Cross-USD-245-6-Mn-by-2031-with-CAGR-of-4-8-Transparency-Market-Research.html

𝐀𝐛𝐨𝐮𝐭 𝐓𝐫𝐚𝐧𝐬𝐩𝐚𝐫𝐞𝐧𝐜𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com   
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter| Blog | YouTube

This release was published on openPR.